相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The CD6/ALCAM pathway promotes lupus nephritis via T cell-mediated responses
Samantha A. Chalmers et al.
JOURNAL OF CLINICAL INVESTIGATION (2022)
Urinary Biomarkers in Lupus Nephritis: Are We There Yet?
Chi Chiu Mok et al.
ARTHRITIS & RHEUMATOLOGY (2021)
ALCAM/CD166: A pleiotropic mediator of cell adhesion, stemness and cancer progression
Fatima Ferragut et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2021)
Properdin Is a Modulator of Tumour Immunity in a Syngeneic Mouse Melanoma Model
Izzat A. M. Al-Rayahi et al.
MEDICINA-LITHUANIA (2021)
Properdin oligomers adopt rigid extended conformations supporting function
Dennis Pedersen et al.
ELIFE (2021)
Prognostic Value of Complement Properdin in Cancer
Alessandro Mangogna et al.
FRONTIERS IN IMMUNOLOGY (2021)
Enumerating the role of properdin in the pathogenesis of IgA nephropathy and its possible therapies
Srijit Ghosh et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
ALCAM and VCAM-1 as urine biomarkers of activity and long-term renal outcome in systemic lupus erythematosus
Ioannis Parodis et al.
RHEUMATOLOGY (2020)
ALCAM predicts future cardiovascular death in acute coronary syndromes: Insights from the PLATO trial
Thor Ueland et al.
ATHEROSCLEROSIS (2020)
Physicochemical Characteristics of Platelet Factor 4 under Various Conditions are Relevant for Heparin-Induced Thrombocytopenia Testing
Van-Chien Bui et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2020)
Comprehensive aptamer-based screening identifies a spectrum of urinary biomarkers of lupus nephritis across ethnicities
Samantha Stanley et al.
NATURE COMMUNICATIONS (2020)
THE alternative complement pathway in ANCA-associated vasculitis: further evidence and a meta-analysis
S. Moiseev et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2020)
High fractional excretion of glycation adducts is associated with subsequent early decline in renal function in type 1 diabetes
Bruce A. Perkins et al.
SCIENTIFIC REPORTS (2020)
Complement Properdin Determines Disease Activity in MRL/lprMice
Hasanain Alaridhee et al.
MEDICINA-LITHUANIA (2020)
Urinary activated leukocyte cell adhesion molecule as a novel biomarker of lupus nephritis histology
Huihua Ding et al.
ARTHRITIS RESEARCH & THERAPY (2020)
Novel Assays to Distinguish Between Properdin-Dependent and Properdin-Independent C3 Nephritic Factors Provide Insight Into Properdin-Inhibiting Therapy
Marloes A. H. M. Michels et al.
FRONTIERS IN IMMUNOLOGY (2019)
ALCAM Mediates DC Migration Through Afferent Lymphatics and Promotes Allospecific Immune Reactions
Ann-Helen Willrodt et al.
FRONTIERS IN IMMUNOLOGY (2019)
2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus
Martin Aringer et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Properdin: A Novel Target for Neuroprotection in Neonatal Hypoxic-Ischemic Brain Injury
Claudia Sisa et al.
FRONTIERS IN IMMUNOLOGY (2019)
Urinary Properdin and sC5b-9 Are Independently Associated With Increased Risk for Graft Failure in Renal Transplant Recipients
Rosa G. M. Lammerts et al.
FRONTIERS IN IMMUNOLOGY (2019)
Identification of Low-Abundance Urinary Biomarkers in Lupus Nephritis Using Electrochemiluminescence Immunoassays
Samantha Stanley et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Fractional excretion as a new marker of tubular damage in children with chronic kidney disease
Kinga Musial et al.
CLINICA CHIMICA ACTA (2018)
Urinary Biochemistry in the Diagnosis of Acute Kidney Injury
Camila Lima et al.
DISEASE MARKERS (2018)
Blocking Properdin Prevents Complement-Mediated Hemolytic Uremic Syndrome and Systemic Thrombophilia
Yoshiyasu Ueda et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices
Ingeborg M. Bajema et al.
KIDNEY INTERNATIONAL (2018)
Properdin binds independent of complement activation in an in vivo model of anti-glomerular basement membrane disease
Joseph O'Flynn et al.
KIDNEY INTERNATIONAL (2018)
Urinary angiostatin, CXCL4 and VCAM-1 as biomarkers of lupus nephritis
Chi Chiu Mok et al.
ARTHRITIS RESEARCH & THERAPY (2018)
Urine angiostatin and VCAM-1 surpass conventional metrics in predicting elevated renal pathology activity indices in lupus nephritis
Samar Soliman et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2017)
A discrete cluster of urinary biomarkers discriminates between active systemic lupus erythematosus patients with and without glomerulonephritis
Carolina Landolt-Marticorena et al.
ARTHRITIS RESEARCH & THERAPY (2016)
Elevated expression of platelet-derived chemokines in patients with antiphospholipid syndrome
Markos D. Patsouras et al.
JOURNAL OF AUTOIMMUNITY (2015)
Renal Elimination of Sclerostin Increases With Declining Kidney Function
Daniel Cejka et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis
L. van Bon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
VEGF, PF4 and PDGF are elevated in platelets of colorectal cancer patients
Jon E. Peterson et al.
ANGIOGENESIS (2012)
Systemic lupus erythematosus one disease or many?
N. Agmon-Levin et al.
AUTOIMMUNITY REVIEWS (2012)
The role of the CXC chemokines platelet factor-4 (CXCL4/PF-4) and its variant (CXCL4L1/PF-4var) in inflammation, angiogenesis and cancer
Jo Vandercappellen et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2011)
The CXC-Chemokine CXCL4 Interacts with Integrins Implicated in Angiogenesis
Sallouha Aidoudi et al.
PLOS ONE (2008)
Platelet factor 4: An inhibitor of angiogenesis
A Bikfalvi
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2004)
分享论文
